enGene Holdings Inc.
Status: Publicly traded
Direct answer
enGene Holdings Inc. is publicly traded on NASDAQ under the ticker ENGN.
Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to...
Can you invest in enGene Holdings Inc.?
Yes. enGene Holdings Inc. trades publicly on NASDAQ as ENGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for enGene Holdings Inc.
Detailed equity research is provided by MarketSnap.